Yamada Yutaka, Takamura Yoshihiro, Saito Kazuma, Minamoto Akira, Ishigooka Gaku, Koto Takashi, Nakano Yuki, Tsuiki Eiko, Terasaki Hiroto, Shimizu Miho, Kimura Masayo, Mitamura Yoshinori, Sekine Reio, Mizusawa Yutaro, Hirano Takao, Oyama Tomoyuki, Iwase Takeshi, Higashijima Fumiaki, Matsubara Hisashi, Inatani Masaru
Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Yoshida, Japan.
Department of Ophthalmology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Graefes Arch Clin Exp Ophthalmol. 2025 May 6. doi: 10.1007/s00417-025-06845-2.
To evaluate the efficacy of vitrectomy, with and without cataract surgery, for diabetic macular edema (DME) in Japan.
This retrospective study was conducted at 22 sites in Japan and enrolled patients who underwent vitrectomy either without (VIT group) or with (VIT + CS group) cataract surgery. Central retinal thickness (CRT) and best-corrected visual acuity (BCVA) were measured before surgery and at 1, 3, 6, and 12 months after surgery.
A total of 722 patients with DME (482 in the VIT + CS group and 240 in the VIT group) were enrolled. CRT significantly decreased after 1 month and continued thereafter in both groups. BCVA significantly improved at 1 month in the VIT + CS group and at 6 months in the VIT group. In both groups, regardless of epiretinal membrane removal, CRT and BCVA significantly improved, with no additional benefit from concomitant internal limiting membrane peeling. The change in BCVA was significantly correlated with the change in CRT during 6 months postoperatively in all patients and in the VIT group. Patients with worse preoperative visual acuity had a higher likelihood of improved BCVA at 6 and 12 months after surgery. No significant difference in BCVA was observed before and after surgery in patients with a preoperative visual acuity of 20/40 or better. However, in patients with a visual acuity of 20/50 or worse, BCVA significantly improved 1 month after surgery.
Vitrectomy is anatomically and functionally effective for DME, and combined cataract surgery is beneficial in DME cases with cataracts. Patients with poor preoperative BCVA improved, while those with good vision maintained it. However, better preoperative vision increased the risk of postoperative deterioration, underscoring the need for careful evaluation of surgical indications.
What is known In vitrectomy for diabetic macular edema (DME), DRCR.net showed that 13-31% of patients experience decreased vision despite reduced edema, leaving the efficacy of vitrectomy uncertain. What is new Our multicenter study demonstrated that vitrectomy with and without cataract surgery was effective in improving central retinal thickness and visual acuity in the patients with DME. Better preoperative visual acuity increased the risk of postoperative decline, and thus the need for careful evaluation of surgical indications.
评估在日本,玻璃体切除术联合或不联合白内障手术治疗糖尿病性黄斑水肿(DME)的疗效。
这项回顾性研究在日本的22个地点进行,纳入了接受了不进行白内障手术(玻璃体切除术组)或进行白内障手术(玻璃体切除术联合白内障手术组)的玻璃体切除术的患者。在手术前以及手术后1、3、6和12个月测量中心视网膜厚度(CRT)和最佳矫正视力(BCVA)。
共纳入722例DME患者(玻璃体切除术联合白内障手术组482例,玻璃体切除术组240例)。两组患者术后1个月CRT均显著降低,此后持续降低。玻璃体切除术联合白内障手术组术后1个月BCVA显著改善,玻璃体切除术组术后6个月BCVA显著改善。在两组中,无论是否切除视网膜前膜,CRT和BCVA均显著改善,同时进行内界膜剥除并无额外益处。所有患者及玻璃体切除术组术后6个月内,BCVA的变化与CRT的变化显著相关。术前视力较差的患者在术后6个月和12个月时BCVA改善的可能性更高。术前视力为20/40或更好的患者手术前后BCVA无显著差异。然而,视力为20/50或更差的患者术后1个月BCVA显著改善。
玻璃体切除术在解剖学和功能上对DME有效,联合白内障手术对合并白内障的DME病例有益。术前BCVA较差的患者视力得到改善,而视力较好的患者维持了视力。然而,术前视力较好会增加术后视力恶化的风险,这突出了仔细评估手术指征的必要性。
已知情况 在糖尿病性黄斑水肿(DME)的玻璃体切除术中,DRCR.net显示,尽管水肿减轻,但13%-31%的患者视力下降,玻璃体切除术的疗效尚不确定。新发现 我们的多中心研究表明,玻璃体切除术联合或不联合白内障手术对DME患者改善中心视网膜厚度和视力均有效。术前视力较好会增加术后视力下降的风险,因此需要仔细评估手术指征。